0028

COM:SZWG

深圳市卫光生物制品股份有限公司

  • Stock

Last Close

27.60

25/11 07:04

Market Cap

6.41B

Beta: -

Volume Today

926.73K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
191.35M
-
237.56M
24.15%
261.05M
9.89%
319.11M
22.24%
404.72M
26.83%
471.91M
16.60%
481.86M
2.11%
425.82M
11.63%
402.80M
5.41%
513.59M
27.51%
639.25M
24.47%
average payables
10.65M
-
10.42M
2.14%
8.43M
19.09%
7.51M
10.89%
8.21M
9.19%
12.94M
57.74%
18.12M
40.02%
22.04M
21.61%
26.54M
20.42%
31.06M
17.04%
55.34M
78.19%
average receivables
10.44M
-
10.91M
4.57%
9.39M
13.96%
12.63M
34.52%
56.72M
349.02%
132.92M
134.34%
202.48M
52.33%
244.66M
20.83%
232.93M
4.79%
219.24M
5.88%
183.26M
16.41%
book value per share
1.32
-
1.81
37.48%
2.31
27.48%
2.97
28.64%
6.07
104.12%
5.76
5.18%
9.58
66.33%
9.90
3.38%
7.80
21.23%
8.12
4.07%
8.88
9.43%
capex per share
-0.34
-
-0.23
32.82%
-0.50
123.77%
-0.35
30.22%
-0.31
12.00%
-0.37
20.33%
-0.51
38.08%
-1.17
126.99%
-1.06
9.08%
-1.44
35.93%
-1.45
0.46%
capex to depreciation
-1.92
-
-0.98
48.88%
-2.14
118.81%
-1.49
30.24%
-1.48
1.31%
-2.02
36.97%
-1.96
3.24%
-4.14
111.64%
-4.34
4.90%
-5.02
15.58%
-3.77
24.92%
capex to operating cash flow
-2.72
-
-0.29
89.48%
-0.57
100.01%
-0.47
17.15%
-2.14
352.44%
-0.85
60.41%
-0.42
50.66%
-0.62
48.58%
-0.98
56.72%
-273.03
27,889.88%
-0.83
99.70%
capex to revenue
-0.16
-
-0.08
47.12%
-0.17
102.24%
-0.11
38.26%
-0.10
6.99%
-0.12
24.80%
-0.09
22.91%
-0.21
120.86%
-0.27
26.89%
-0.49
84.68%
-0.31
36.01%
cash per share
0.41
-
0.67
60.76%
0.70
5.02%
0.36
48.07%
1.71
370.43%
1.15
32.90%
2.01
75.52%
2.88
43.16%
1.36
52.83%
1.30
4.54%
1.11
14.35%
days of inventory on hand
465.89
-
355.56
23.68%
376.70
5.94%
443.17
17.65%
470.81
6.24%
436.94
7.19%
337.30
22.80%
246.61
26.89%
286.87
16.32%
517.56
80.42%
399.24
22.86%
days payables outstanding
24.79
-
12.50
49.57%
11.22
10.27%
8.33
25.77%
10.11
21.43%
14.33
41.76%
14.41
0.51%
15.48
7.48%
19.71
27.32%
28.33
43.72%
46.00
62.38%
days sales outstanding
12.63
-
7.69
39.15%
6.74
12.36%
10.33
53.31%
57.04
452.32%
89.36
56.65%
105.10
17.61%
102.00
2.95%
85.71
15.97%
123.18
43.72%
49.12
60.12%
debt to assets
0.53
-
0.46
13.31%
0.42
7.99%
0.32
23.67%
0.05
84.28%
0.02
60.97%
0.04
-
0.02
51.47%
0.21
879.90%
0.18
14.00%
debt to equity
1.69
-
1.15
32.16%
0.92
19.72%
0.58
36.92%
0.06
90.01%
0.02
61.83%
0.05
-
0.02
51.98%
0.30
1,110.45%
0.26
12.22%
dividend yield
0.04
-
0.01
70.40%
0.02
86.05%
0.02
15.30%
0.02
8.99%
0.01
28.36%
0.01
34.97%
0.01
26.10%
0.01
11.17%
0.01
38.11%
0.01
3.24%
earnings yield
0.03
-
0.04
12.73%
0.04
24.19%
0.05
22.73%
0.03
42.51%
0.04
18.91%
0.05
25.34%
0.03
25.11%
0.03
18.23%
0.02
42.76%
0.03
69.02%
enterprise value
3.13B
-
3.08B
1.84%
3.08B
0.08%
3.07B
0.37%
4.71B
53.57%
4.01B
14.93%
3.39B
15.29%
5.10B
50.23%
6.95B
36.36%
7.49B
7.65%
8.24B
10.08%
enterprise value over ebitda
21.98
-
16.36
25.54%
14.60
10.79%
12.90
11.62%
19.60
51.89%
17.46
10.88%
14.01
19.79%
19.29
37.71%
23.13
19.94%
39.51
70.78%
24.12
38.95%
ev to operating cash flow
149.74
-
22.93
84.69%
20.51
10.54%
24.27
18.30%
164.61
578.40%
40.26
75.54%
18.28
54.59%
16.78
8.22%
28.17
67.89%
6.24K
22,064.46%
20.71
99.67%
ev to sales
8.82
-
6.79
22.99%
6.15
9.55%
5.42
11.84%
7.56
39.46%
5.82
22.91%
4.13
29.06%
5.64
36.43%
7.66
35.93%
11.21
46.24%
7.86
29.87%
free cash flow per share
-0.21
-
0.56
365.17%
0.38
32.95%
0.39
3.54%
-0.17
142.31%
0.07
140.10%
0.71
977.03%
0.71
0.73%
0.03
96.23%
-1.44
5,482.34%
0.30
121.18%
free cash flow yield
-0.01
-
0.03
365.17%
0.02
32.95%
0.02
3.54%
-0.01
128.03%
0.00
153.92%
0.03
722.72%
0.02
28.33%
0.00
96.00%
-0.05
5,489.67%
0.01
119.23%
graham net net
-1.74
-
-1.28
26.47%
-1.16
8.97%
-0.87
24.82%
2.34
368.34%
2.12
9.50%
3.83
80.60%
3.93
2.55%
2.05
47.92%
0.26
87.46%
-0.60
334.59%
graham number
3.94
-
4.91
24.49%
6.18
25.83%
7.76
25.65%
10.33
33.09%
9.46
8.43%
15.63
65.21%
16.18
3.55%
12.61
22.08%
9.72
22.87%
13.88
42.74%
income quality
0.24
-
1.33
466.72%
1.20
9.92%
0.82
31.37%
0.18
77.59%
0.64
243.68%
1.09
70.74%
1.60
47.77%
1.20
24.88%
0.01
99.18%
1.83
18,377.85%
intangibles to total assets
0.11
-
0.13
10.98%
0.11
10.06%
0.10
7.86%
0.07
33.99%
0.07
5.53%
0.07
1.75%
0.06
13.81%
0.05
10.21%
0.04
19.53%
0.06
39.50%
interest coverage
4.76
-
4.47
6.05%
5.61
25.47%
9.34
66.28%
13.88
48.65%
48.52
249.60%
498.25
926.97%
208.89
58.08%
87.19
58.26%
67.18
22.96%
17.25
74.32%
interest debt per share
2.35
-
2.23
5.10%
2.28
2.18%
1.84
19.39%
0.42
77.24%
0.14
65.48%
0.00
98.17%
0.51
19,295.43%
0.20
60.27%
2.42
1,088.56%
2.38
1.69%
inventory turnover
0.78
-
1.03
31.03%
0.97
5.61%
0.82
15.00%
0.78
5.87%
0.84
7.75%
1.08
29.54%
1.48
36.77%
1.27
14.03%
0.71
44.57%
0.91
29.64%
invested capital
1.69
-
1.15
32.16%
0.92
19.72%
0.58
36.92%
0.06
90.01%
0.02
61.83%
0.05
-
0.02
51.98%
0.30
1,110.45%
0.26
12.22%
market cap
2.82B
-
2.83B
0.35%
2.83B
0.01%
2.83B
0.00%
4.98B
75.68%
4.24B
14.88%
3.70B
12.73%
5.49B
48.39%
7.24B
31.95%
7.23B
0.13%
7.97B
10.15%
net current asset value
-176.86M
-
-92.86M
47.49%
-57.90M
37.65%
35.70M
161.66%
712.79M
1,896.44%
771.53M
8.24%
871.51M
12.96%
909.33M
4.34%
784.13M
13.77%
424.92M
45.81%
272.57M
35.86%
net debt to ebitda
2.17
-
1.28
40.70%
1.16
9.90%
0.98
15.37%
-1.12
214.22%
-1.01
9.91%
-1.26
24.68%
-1.47
17.20%
-0.96
34.81%
1.33
238.73%
0.80
40.00%
net income per share
0.52
-
0.59
12.73%
0.73
24.19%
0.90
22.73%
0.78
13.23%
0.69
11.57%
1.13
64.09%
1.18
3.71%
0.91
22.93%
0.52
42.84%
0.96
86.19%
operating cash flow per share
0.12
-
0.79
538.84%
0.88
11.88%
0.74
15.78%
0.14
80.55%
0.44
203.92%
1.23
179.84%
1.88
52.77%
1.09
41.98%
0.01
99.51%
1.75
33,090.87%
payables turnover
14.73
-
29.20
98.29%
32.54
11.45%
43.84
34.71%
36.10
17.65%
25.47
29.46%
25.34
0.50%
23.58
6.96%
18.52
21.46%
12.88
30.42%
7.93
38.42%
receivables turnover
28.89
-
47.49
64.34%
54.18
14.10%
35.34
34.77%
6.40
81.89%
4.08
36.16%
3.47
14.98%
3.58
3.04%
4.26
19.01%
2.96
30.42%
7.43
150.75%
research and ddevelopement to revenue
0.03
-
0.04
29.74%
0.04
10.83%
0.04
6.06%
0.03
16.19%
0.05
41.92%
0.05
1.96%
0.05
5.19%
0.05
2.40%
0.06
12.99%
return on tangible assets
0.14
-
0.15
6.26%
0.16
10.07%
0.19
14.31%
0.12
35.69%
0.12
4.26%
0.12
0.55%
0.11
5.06%
0.11
1.77%
0.05
56.03%
0.08
69.80%
revenue per share
2.09
-
2.66
27.02%
2.94
10.65%
3.33
13.02%
3.15
5.39%
3.03
3.58%
5.43
79.11%
5.58
2.78%
4.00
28.35%
2.94
26.40%
4.62
56.99%
roe
0.40
-
0.33
18.00%
0.32
2.58%
0.30
4.59%
0.13
57.49%
0.12
6.74%
0.12
1.35%
0.12
0.32%
0.12
2.16%
0.06
45.07%
0.11
70.14%
roic
0.13
-
0.14
8.35%
0.16
10.31%
0.18
14.04%
0.12
33.05%
0.12
2.31%
0.12
1.06%
0.11
4.57%
0.11
0.84%
0.05
54.88%
0.09
70.28%
sales general and administrative to revenue
0.13
-
0.03
79.92%
0.03
4.42%
0.03
8.23%
0.03
0.64%
0.03
12.59%
0.03
14.56%
0.03
2.95%
0.02
24.63%
0.03
15.62%
0.02
12.73%
shareholders equity per share
1.32
-
1.81
37.48%
2.31
27.48%
2.97
28.64%
6.07
104.12%
5.76
5.18%
9.58
66.33%
9.90
3.38%
7.80
21.23%
8.12
4.07%
8.88
9.43%
stock based compensation to revenue
tangible asset value
143.41M
-
212.43M
48.13%
297.25M
39.93%
411.97M
38.59%
1.11B
169.18%
1.20B
8.23%
1.34B
11.32%
1.51B
13.11%
1.68B
11.03%
1.75B
4.50%
1.87B
6.53%
tangible book value per share
0.85
-
1.25
47.62%
1.75
39.94%
2.42
38.60%
5.60
131.28%
5.29
5.44%
8.84
66.98%
9.33
5.58%
7.40
20.69%
7.73
4.49%
8.24
6.54%
working capital
-9.04M
-
3.76M
141.62%
94.37M
2,408.05%
165.70M
75.58%
777.94M
369.48%
809.56M
4.07%
905.10M
11.80%
937.20M
3.55%
832.20M
11.20%
903.37M
8.55%
837.72M
7.27%

All numbers in (except ratios and percentages)